A Pharmacokinetic-Pharmacodynamic Assessment of the Hepatic and Bone-Marrow Toxicities of the New Trypanoside Fexinidazole

Antimicrobial Agents and Chemotherapy - United States
doi 10.1128/aac.02515-18
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society for Microbiology

Related search

New Sampling Techniques for Pharmacokinetic- Pharmacodynamic Modeling

2012English

A Population Pharmacokinetic-Pharmacodynamic Model of Pegfilgrastim

AAPS Journal
Pharmaceutical Science
2018English

Evaluation of the Pharmacodynamic and Pharmacokinetic Interaction Between Pagoclone and Ethanol.

Clinical Pharmacology and Therapeutics
Pharmacology
2003English

Pharmacokinetic and Pharmacodynamic Properties of a Long-Acting Formulation of the New Somatostatin Analogue, Lanreotide, in Normal Healthy Volunteers.

British Journal of Clinical Pharmacology
Pharmacology
1994English

Pharmacokinetic and Pharmacodynamic Considerations of Rifamycin Antibiotics for the Treatment of Tuberculosis

Expert Opinion on Drug Metabolism and Toxicology
MedicineToxicologyPharmacology
2019English

Aplasia of the Bone Marrow: A New Cause of the Von Jaksch Syndrome

Archives of Disease in Childhood
Child HealthPediatricsPerinatology
1952English

Clinical Pharmacokinetic, Pharmacodynamic and Drug-Interaction Profile of the Integrase Inhibitor Dolutegravir

Clinical Pharmacokinetics
Pharmacology
2013English

Pharmacokinetic and Pharmacodynamic Evaluation of Rivaroxaban: Considerations for the Treatment of Venous Thromboembolism

Thrombosis Journal
Hematology
2014English

The Kinetics of Integrilin Limited by Obesity: A Multicenter Randomized Pharmacokinetic and Pharmacodynamic Clinical Trial

American Heart Journal
Cardiovascular MedicineCardiology
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy